News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,667 Results
Type
Article (5346)
Company Profile (18)
Press Release (227303)
Multimedia
Podcasts (1)
Webinars (4)
Section
Business (84096)
Career Advice (472)
Deals (15312)
Drug Delivery (8)
Drug Development (20197)
Employer Resources (32)
FDA (3910)
Job Trends (4193)
News (123872)
Policy (7964)
Tag
Academia (324)
Accelerated approval (2)
Adcomms (3)
Allergies (10)
Alliances (15365)
ALS (20)
Alzheimer's disease (249)
Antibody-drug conjugate (ADC) (14)
Approvals (3935)
Artificial intelligence (42)
Autoimmune disease (3)
Automation (4)
Bankruptcy (97)
Best Places to Work (3137)
Biosimilars (14)
Biotechnology (22)
Bladder cancer (11)
Brain cancer (7)
Breast cancer (50)
Cancer (487)
Cardiovascular disease (25)
Career advice (401)
Career pathing (3)
CAR-T (34)
Cell therapy (111)
Cervical cancer (2)
Clinical research (17051)
Collaboration (180)
Compensation (171)
Complete response letters (2)
COVID-19 (310)
CRISPR (8)
C-suite (110)
Cystic fibrosis (16)
Data (557)
Depression (7)
Diabetes (46)
Diagnostics (2057)
Digital health (3)
Diversity, equity & inclusion (14)
Drug discovery (16)
Drug pricing (20)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (41416)
Editorial (3)
Employer branding (6)
Employer resources (33)
Events (39034)
Executive appointments (322)
FDA (4185)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (192)
Gene editing (16)
Generative AI (2)
Gene therapy (54)
GLP-1 (118)
Government (493)
Guidances (18)
Healthcare (5265)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (15)
Indications (6)
Infectious disease (326)
Inflammatory bowel disease (27)
Inflation Reduction Act (3)
Influenza (3)
Intellectual property (17)
Interviews (56)
IPO (7931)
IRA (5)
Job creations (1150)
Job search strategy (365)
Kidney cancer (7)
Labor market (5)
Layoffs (108)
Leadership (5)
Legal (2433)
Liver cancer (18)
Lung cancer (58)
Lymphoma (40)
Management (10)
Manufacturing (53)
MASH (28)
Medical device (3913)
Medtech (3914)
Mergers & acquisitions (7600)
Metabolic disorders (129)
Multiple sclerosis (11)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (356)
NextGen: Class of 2025 (1734)
Non-profit (758)
Now hiring (4)
Obesity (54)
Opinion (32)
Ovarian cancer (18)
Pain (13)
Pancreatic cancer (14)
Parkinson's disease (30)
Partnered (4)
Patents (27)
Patient recruitment (33)
Peanut (5)
People (25262)
Pharmaceutical (6)
Pharmacy benefit managers (20)
Phase I (5045)
Phase II (7331)
Phase III (5961)
Pipeline (574)
Policy (17)
Postmarket research (677)
Preclinical (1981)
Press Release (66)
Prostate cancer (28)
Psychedelics (3)
Radiopharmaceuticals (111)
Rare diseases (73)
Real estate (1944)
Recruiting (8)
Regulatory (5430)
Reports (14)
Research institute (323)
Resumes & cover letters (70)
Rett syndrome (4)
Schizophrenia (25)
Series A (29)
Series B (23)
Sickle cell disease (7)
Special edition (3)
Spinal muscular atrophy (28)
Sponsored (5)
Startups (1046)
Stomach cancer (1)
Supply chain (11)
Tariffs (5)
The Weekly (1)
Vaccines (38)
Venture capitalists (2)
Weight loss (25)
Women's health (1)
Date
Today (58)
Last 7 days (230)
Last 30 days (739)
Last 365 days (10328)
2025 (3290)
2024 (11437)
2023 (13641)
2022 (19126)
2021 (20254)
2020 (18803)
2019 (13774)
2018 (10635)
2017 (10310)
2016 (9483)
2015 (12485)
2014 (9915)
2013 (7957)
2012 (8624)
2011 (9111)
2010 (8927)
Location
Africa (189)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11996)
Australia (1737)
California (2010)
Canada (719)
China (80)
Colorado (85)
Connecticut (98)
Delaware (31)
Europe (25196)
Florida (285)
Georgia (37)
Idaho (23)
Illinois (118)
India (9)
Indiana (64)
Iowa (2)
Japan (74)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (230)
Massachusetts (1604)
Michigan (85)
Minnesota (143)
Mississippi (1)
Missouri (25)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (16)
New Jersey (755)
New Mexico (5)
New York (498)
North Carolina (333)
North Dakota (3)
Northern California (954)
Ohio (60)
Oklahoma (5)
Oregon (4)
Pennsylvania (358)
Puerto Rico (1)
Rhode Island (13)
South America (280)
South Carolina (5)
Southern California (729)
Tennessee (40)
Texas (234)
United States (7453)
Utah (61)
Virginia (47)
Washington D.C. (12)
Washington State (180)
West Virginia (2)
Wisconsin (25)
232,667 Results for "princeton biomeditech corporation pbm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
C2Sense® and Princeton BioMeditech Receive Second Award from NIH RADx® Tech High Performance Program for Digitally Connected, At-Home Diagnostic Reader and Multiplex COVID-19/Flu A&B Rapid Test
C2Sense, Inc., experts in advanced optical sensing platforms and Princeton BioMeditech Corporation, a world leader in rapid, point-of-care diagnostics, announced that they have secured a second National Institutes of Health Rapid Acceleration of Diagnostics Tech High Performance award.
April 9, 2024
·
3 min read
PBMs
Deep Dive: PBM Reform
In the battle over drug prices, one sector of the healthcare industry has risen above all the players as the boogeyman: pharmacy benefit managers. In this special edition of BioPharm Executive,
BioSpace
takes a deep dive into the lens now focused on PBMs’ business practices.
September 18, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
Novo Nordisk announces that CVS Caremark®, the country’s largest PBM, has decided Wegovy® will be the preferred GLP-1 medicine covered for obesity on its template formularies
May 1, 2025
·
9 min read
Press Releases
AHF Wins $10+ Million Against Prime Therapeutics in PBM Price-Fixing Arbitration
January 23, 2025
·
3 min read
Press Releases
BioCentriq Partners with Orchestra Life Sciences to Advance Princeton, NJ Cell Therapy Facility Development
January 15, 2025
·
5 min read
Press Releases
BioCentriq Expands Operations and Secures Cell Therapy Manufacturing Facility in Princeton, NJ
December 18, 2024
·
3 min read
Pharmacy benefit managers
Can PBM Reform Lower Drug Prices?
Healthcare players are pointing fingers amid regulatory crackdowns on pharmacy benefit managers, but proposed reforms wouldn’t address a dearth of competition in the larger market.
September 11, 2024
·
5 min read
·
Keerthi Vedantam
Business
Novo CEO Reluctantly Agrees to Meet With PBMs on Ozempic, Wegovy Prices
In a Tuesday Senate hearing on Novo Nordisk’s drug pricing, CEO Lars Fruergaard Jørgensen said he would be willing to sit down with the three largest pharmacy benefit managers who committed that they would expand coverage of Ozempic and Wegovy if Novo lowers its list prices for the blockbuster drugs.
September 25, 2024
·
3 min read
·
Greg Slabodkin
Pharmacy benefit managers
House Oversight Chair Calls on PBM Execs to Correct Testimonies
The chair of the House Committee on Oversight and Accountability wants the CEOs of CVS Caremark, Express Scripts and Optum Rx to fix statements they made in a hearing last month that contradicted the committee’s and Federal Trade Commission’s findings.
August 29, 2024
·
2 min read
·
Tristan Manalac
Business
Express Scripts Sues FTC, Demands Withdrawal of ‘False and Misleading’ PBM Report
Pharmacy benefit manager Express Scripts announced Tuesday it has filed a lawsuit in federal court in Missouri against the Federal Trade Commission for its “unfair, biased and erroneous” July report on the industry.
September 17, 2024
·
2 min read
·
Kate Goodwin
1 of 23,267
Next
